Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Approach to persistent ascites after liver transplantation (CROSBI ID 322960)

Prilog u časopisu | stručni rad | međunarodna recenzija

Ostojić, Ana ; Petrović, Igor ; Silovski, Hrvoje ; Košuta, Iva ; Sremac, Maja ; Mrzljak, Anna Approach to persistent ascites after liver transplantation // World journal of hepatology, 14 (2022), 9; 1739-1746. doi: 10.4254/wjh.v14.i9.1739

Podaci o odgovornosti

Ostojić, Ana ; Petrović, Igor ; Silovski, Hrvoje ; Košuta, Iva ; Sremac, Maja ; Mrzljak, Anna

engleski

Approach to persistent ascites after liver transplantation

Persistent ascites (PA) after liver transplantation (LT), commonly defined as ascites lasting more than 4 wk after LT, can be expected in up to 7% of patients. Despite being relatively rare, it is associated with worse clinical outcomes, including higher 1-year mortality. The cause of PA can be divided into vascular, hepatic, or extrahepatic. Vascular causes of PA include hepatic outflow and inflow obstructions, which are usually successfully treated. Regarding modifiable hepatic causes, recurrent hepatitis C and acute cellular rejection are the leading ones. Considering predictors for PA, the presence of ascites, refractory ascites, hepato-renal syndrome type 1, spontaneous bacterial peritonitis, hepatic encephalopathy, and prolonged ischemic time significantly influence the development of PA after LT. The initial approach to patients with PA should be to diagnose the treatable cause of PA. The stepwise approach in evaluating PA includes diagnostic paracentesis, ultrasound with Doppler, and an echocardiogram when a cardiac cause is suspected. Finally, a percutaneous or transjugular liver biopsy should be performed in cases where the diagnosis is unclear. PA of unknown cause should be treated with diuretics and paracentesis, while transjugular intrahepatic portosystemic shunt and splenic artery embolization are treatment methods in patients with refractory ascites after LT.

acute cellular rejection ; hepatic graft inflow obstructions ; hepatic graft outflow obstructions ; liver transplantation ; liver transplantation complications, ascites

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

14 (9)

2022.

1739-1746

objavljeno

1948-5182

10.4254/wjh.v14.i9.1739

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost